Akkermansia muciniphila is a mucin-degrading, Gram-negative anaerobic bacterium that resides in the intestinal mucus layer and typically represents roughly 1-5% of the human gut microbiota. Its relative abundance is often reduced in people with obesity, type 2 diabetes, hypertension and other metabolic disorders. It is regarded as a 'next-generation' beneficial microbe or postbiotic: a specific outer-membrane protein, Amuc_1100, signals through Toll-like receptor 2, and notably a pasteurized (non-living) form has retained or even enhanced its metabolic effects in preclinical models.
In a randomized, double-blind proof-of-concept trial in overweight or obese insulin-resistant adults, three months of daily supplementation with A. muciniphila (particularly the pasteurized form, at 10^10 cells/day) was safe and improved insulin sensitivity (+28.6%), insulinemia (-34%) and total cholesterol (-8.7%) while lowering markers of liver dysfunction and inflammation. Follow-up trials have since reported weight-loss maintenance in people with overweight and obesity and improved muscle strength with a pasteurized strain, but results are mixed: a 2025 trial in type 2 diabetes found benefits only in participants whose baseline gut Akkermansia was low, and a larger 2026 multicenter trial in metabolic syndrome missed its primary insulin-sensitivity endpoint overall, with benefits confined to prediabetic, older (63+) and low-baseline subgroups. Mechanistically the bacterium thickens the gut mucus layer, strengthens the intestinal barrier and modulates host immunity. The human trial base remains small—a handful of mostly short trials, several from the same research lineage—with no long-term safety or hard-outcome data, and responses may depend on a person's baseline Akkermansia levels. This evidence describes the microorganism Akkermansia muciniphila and its mechanisms in general, not this specific commercial product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“Akkermansia muciniphila supplementation was safe and well tolerated and improved insulin sensitivity and markers of metabolic health in overweight, insulin-resistant adults.”
“The primary endpoint of whole-body insulin sensitivity (Matsuda index) did not differ after 4-months of daily administration of capsules containing 30 billion cells of pasteurizedMucT compared to placebo in the intention-to-treat subjects.”
“We demonstrated that Amuc_1100, a specific protein isolated from the outer membrane of A. muciniphila, interacts with Toll-like receptor 2, is stable at temperatures used for pasteurization, improves the gut barrier and partly recapitulates the beneficial effects of the bacterium.”
“A. muciniphila is associated with a healthier metabolic status and better clinical outcomes after CR in overweight/obese adults.”
“Although there are studies that support the protective effect of this strategy, the effects on the prevention of obesity on humans are not clear yet and need more investigation.”
“Bifidobacterium and Lactobacillus strains are still the most widely used probiotics in functional foods and dietary supplements, but next generation probiotics, such as Faecalibacterium prausnitzii, Akkermansia muciniphila, or Clostridia strains, have demonstrated promising results.”
Research describes the active mechanism and is not a claim about this specific product.
Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…
Across meta-analyses and randomized trials, creatine monohydrate combined with…
In humans, randomized trials and meta-analyses most consistently show that astaxanthin…
Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…
Yes — its active compound is linked to 14 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.